Avoid common mistakes on your manuscript.
Liakakos et al. [1] concluded from a retrospective series of 1,057 selected patients studied by Miyajima et al. [2] that laparoscopic surgery for rectal cancer is safe. Although cohort studies have shown safety, the most important outcomes such as disease-free survival and the recurrence rate need to be demonstrated in prospective randomized controlled trials before laparoscopic surgery is accepted as the standard approach.
Laparoscopic resection of colonic cancer is proved to be safe, with no difference in long-term oncologic outcome compared with open surgery [3–5]. However, long-term outcome data after laparoscopic surgery for rectal cancer still are not available.
Only 5 years ago, the first study investigating the quality of the mesorectal dissection with 25 patients was published [6]. The first randomization was done in the conventional versus laparoscopically-assisted surgery in Colorectal Cancer (CLASICC) trial with 253 patients treated with laparoscopic surgery. The conversion rate at the beginning of the trial was 34%, which decreased to 16% during the sixth year of the study [5]. This high conversion rate in a relatively small study group was due the experience curve effect.
Miyajima et al. [2] concluded that laparoscopy is feasible and safe for selected patients with rectal cancer, with favorable short- and mid-term outcomes after a mean follow-up period of 30 months. This retrospective study, not intended to be a comparison between open and laparoscopic surgery, was reported without long-term outcome data. Therefore, as stated by Liakakos et al. [1], more data are needed from randomized controlled trials, if feasible, to support the hypothesis of better oncologic outcomes for closed rather than open surgery for rectal cancer.
Currently, several multicenter randomized controlled trials comparing laparoscopic and open surgery for rectal cancer are registered (Clinicaltrials.gov) and recruiting patients, including the laparoscopic-assisted resection or open resection in treating patients with Stage IIA, Stage IIIA, or Stage IIIB rectal cancer (NCT00726622) trial by the American College of Surgeons (estimated primary completion date, August 2010) and the Phase II trial to evaluate laparoscopic surgery for Stage 0/1 rectal carcinoma (Lap RC), NCT00635466 (estimated study completion date, 2016).
In addition, the comparing laparoscopic and open surgery for rectal cancer (COLOR II) trial (NCT00297791) will fulfil the profound need for a well-designed and performed randomized trial. Recently, this COLOR II trial finished randomization of 1,100 patients. The short-term results will be presented by the colorectal cancer laparoscopic or open resection study group on a short notice.
The primary end point of the COLOR II trial is the locoregional recurrence rate 3 years postoperatively. Until these data become available, we believe that open total mesorectal excision must be regarded as the gold standard treatment for rectal cancer.
References
Liakakos T, Kopanakis K, Schizas D (2010) Favorable outcomes with laparoscopic surgery for rectal cancer. Surg Endosc 24:1217–1218
Miyajima N, Fukunaga M, Hasegawa H, Tanaka J, Okuda J, Watanabe M (2009) Results of a multicenter study of 1,057 cases of rectal cancer treated by laparoscopic surgery. Surg Endosc 23:113–118
The Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350:2050–2059
Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy A, Bonjer HJ (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52
Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 25:3061–3068
Breukink SO, Grond AJ, Pierie JP, Hoff C, Wiggers T, Meijerink WJ (2005) Laparoscopic vs open total mesorectal excision for rectal cancer: an evaluation of the mesorectum’s macroscopic quality. Surg Endosc 19:307–310
Disclosures
M. H. G. M. van der Pas, E. A. te Velde, M. A. Cuesta, and H. J. Bonjer have no conflicts of interest or financial ties to disclose.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
van der Pas, M.H.G.M., te Velde, E.A., Cuesta, M.A. et al. Favorable outcomes with laparoscopic surgery for rectal cancer. Surg Endosc 25, 2060–2061 (2011). https://doi.org/10.1007/s00464-010-1457-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-010-1457-4